Company news
Shanghai Bio-Heart Biological Technology Co., Ltd. news
Latest news releases, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026
November 3, 2026
Adoption of the china accounting standards for business enterprises for the preparation of financial reports on a uniform basis and proposed change of auditor
October 22, 2026
List of directors and their roles and functions
October 9, 2026
(1) Poll results of the 2026 first extraordinary general meeting held on October 9, 2026; (2) resignation of independent non-executive director; (3) appointment of independent non-executive director; and (4) change of composition of board committees
October 9, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
October 5, 2026
2026 Interim report
September 29, 2026
Proxy form for use at the 2026 first extraordinary general meeting to be held on October 9, 2026
September 23, 2026
Proposed appointment of independent non-executive director; and (2) notice of 2026 first extraordinary general meeting
September 23, 2026
Notice of 2026 first extraordinary general meeting
September 23, 2026
Announcement pursuant to rule 13.51B(2) of the listing rules
September 16, 2026
Voluntary announcement strategic cooperation agreement with shanghai shenqi medical technology co., ltd. to advance the commercialisation of the bioheart bioabsorbable rapamycin-eluting coronary stent system
September 14, 2026
Articles of association
June 26, 2026